AMORPHE URIDINTRIACETATFORMULIERUNG
European patent · EP4284341 · In force
Register entry
- Publication number
- EP4284341
- Application number
- EP22746580
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 27, 2022
- Published
- Dec 6, 2023
- Granted
- Apr 8, 2026
- Protection ends at the latest
- Jan 26, 2042
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 9/10 (2006.01)A61K 47/38 (2006.01)A61K 47/14 (2017.01)A61K 31/7072 (2006.01)A61K 9/14 (2006.01)A61K 9/16 (2006.01)
- Priority
- US 202163142297 P 27.01.2021
- PCT application
- PCT/US2022/014031 27.01.2022
- PCT publication
- WO2022/164985 04.08.2022
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 19, 2026
Agent entered
- Representative
- Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève
Published in Swissreg on 19.06.2026
- Apr 8, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 08.04.2026
Parties
Inventor
BAMAT, Michael, Kevin
Potomac, MD 20854, US
GAO, Yi
Vernon Hills, IL 60061, US
MILLER, Jeffrey, A.
Lincoln University, PA 19352, US
QIU, Yihong
Vernon Hills, IL 60061, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.